Itraconazole Iv Solution 200 mg/vial Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) solution
Available Strengths: 200 mg/vial
Reference Brands: Sporanox(US & EU)
Category: Anti-fungal
Itraconazole IV inhibits fungal cytochrome P450 14α-demethylase, blocking ergosterol synthesis and disrupting fungal cell membranes. It provides broad-spectrum activity, rapid systemic treatment, and excellent tissue penetration. Benefits include effective management of severe fungal infections, reliable intravenous delivery, and a favorable safety profile for hospitalized patients.
Product Description:
Itraconazole IV solution is approved in the EU and US for severe fungal infections. In the EU, Janssen’s Sporanox IV is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed dossiers for initial approval and continuous safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in regulatory solutions, facilitating efficient market access and ensuring adherence to regulatory standards for itraconazole IV formulations.
Itraconazole Iv Solution — third party manufacturing & bulk supply
Itraconazole Iv Solution 200 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Itraconazole Iv Solution is supplied as Intravenous (IV) solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Itraconazole Iv Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Itraconazole Iv Solution →Frequently Asked Questions
Itraconazole is used to treat a wide range of fungal infections, including aspergillosis, histoplasmosis, blastomycosis, and certain systemic or deep-tissue fungal diseases. It works by inhibiting fungal cell membrane synthesis, helping stop fungal growth and spread.
Itraconazole contains the active triazole antifungal ingredient itraconazole, along with formulation excipients suitable for parenteral administration.
Common trade names include Sporanox and Onmel (region-specific).
Branded versions such as Sporanox are produced by Janssen Pharmaceuticals. Generic itraconazole is manufactured by multiple GMP-approved pharmaceutical companies globally.
The generic name is itraconazole.
Brand names include Sporanox and Onmel.
Itraconazole is manufactured in various GMP-certified facilities worldwide, depending on the brand and market authorization requirements.
Related Products
Itraconazole Oral Solution
Strength:
10 mg/mL
Form: Oral Solution
Reference Brands: Sporanox(US & EU)
View Details
Itraconazole Capsules
Strength:
100 mg
Form: Oral Capsules
Reference Brands: Sporanox(US & EU)
View Details
Ketoconazole Topical Cream/Shampoo
Strength:
2%
Form: Topical Creams/Ointments/Shampoo
Reference Brands: Nizoral(US & EU)
View Details
Micafungin Intravenous (Iv) Powder
Strength:
50 mg, 100 mg/vial
Form: Intravenous (IV) Powder
Reference Brands: Mycamine(US & EU)
View Details
Nystatin Topical Creams And Ointments
Strength:
100,000 units/g, 100,000–300,000 units/g
Form: Topical Creams and Ointments
Reference Brands: Mycostatin, Nilstat, Nystop(US)
View Details
Nystatin Oral Suspensions/Tablets
Strength:
Tab: 500,000 units, 1,000,000 units; Sus: 100,000 units/mL, 500,000 units/5 mL
Form: Tablets/Suspensions
Reference Brands: Mycostatin, Nilstat, Nystop(US)
View Details
Quick Response Guaranteed | Verified Suppliers
